AAPL339.84-3.11 (-0.91%) ▼|ABBV290.72+8.04 (+2.85%) ▲|ABT102.61-1.46 (-1.40%) ▼|ACN238.96+2.03 (+0.86%) ▲|ADBE255.26+8.17 (+3.30%) ▲|AMAT406.46-6.65 (-1.61%) ▼|AMD542.18+4.13 (+0.77%) ▲|AMGN434.83+9.89 (+2.33%) ▲|AMT184.65+1.62 (+0.88%) ▲|AMZN263.10+0.65 (+0.25%) ▲|AVGO335.28+0.69 (+0.21%) ▲|AXP319.86+3.45 (+1.09%) ▲|BA191.31-0.12 (-0.06%) ▼|BAC50.80+0.41 (+0.81%) ▲|BKNG164.47+1.87 (+1.15%) ▲|BLK1,129.24+4.64 (+0.41%) ▲|BMY61.60+2.77 (+4.71%) ▲|BNY144.36+1.92 (+1.35%) ▲|BRK-B537.93+5.70 (+1.07%) ▲|C122.39+0.70 (+0.58%) ▲|CAT726.45+0.66 (+0.09%) ▲|CL94.02+1.16 (+1.24%) ▲|CMCSA22.21+0.31 (+1.39%) ▲|COF201.93+2.10 (+1.05%) ▲|COP145.84+0.60 (+0.41%) ▲|COST995.38-0.15 (-0.02%) ▼|CRM242.07-0.39 (-0.16%) ▼|CSCO106.63+0.13 (+0.12%) ▲|CVS94.11+1.43 (+1.54%) ▲|CVX224.76+0.39 (+0.17%) ▲|DE636.27+9.27 (+1.48%) ▲|DHR225.45+1.02 (+0.45%) ▲|DIS111.60+2.01 (+1.83%) ▲|DUK121.25+1.98 (+1.66%) ▲|EMR159.79-0.76 (-0.47%) ▼|FDX300.57+6.79 (+2.31%) ▲|GD344.41+2.98 (+0.87%) ▲|GE299.48-11.80 (-3.79%) ▼|GEV896.82-11.62 (-1.28%) ▼|GILD156.32+3.25 (+2.12%) ▲|GM75.90-6.86 (-8.28%) ▼|GOOG336.78-3.38 (-0.99%) ▼|GOOGL340.69-3.49 (-1.01%) ▼|GS885.74+9.96 (+1.14%) ▲|HD315.78+5.90 (+1.90%) ▲|HON212.18+2.20 (+1.05%) ▲|IBM240.33+3.94 (+1.67%) ▲|INTC92.54+0.51 (+0.55%) ▲|INTU336.52+10.90 (+3.35%) ▲|ISRG438.78+5.60 (+1.29%) ▲|JNJ259.72+5.93 (+2.34%) ▲|JPM335.76+2.23 (+0.67%) ▲|KO92.75-0.68 (-0.72%) ▼|LIN499.70-3.75 (-0.74%) ▼|LLY1,292.02+51.68 (+4.17%) ▲|LMT549.29+1.06 (+0.19%) ▲|LOW199.33+3.41 (+1.74%) ▲|LRCX265.14-7.06 (-2.59%) ▼|MA622.00+5.60 (+0.91%) ▲|MCD245.62+2.95 (+1.21%) ▲|MDLZ63.87+0.53 (+0.83%) ▲|MDT94.57+1.80 (+1.94%) ▲|META690.14-15.30 (-2.17%) ▼|MMM171.17+9.16 (+5.65%) ▲|MO74.43+0.34 (+0.46%) ▲|MRK148.25+4.62 (+3.22%) ▲|MS180.42+1.95 (+1.09%) ▲|MSFT532.48-1.04 (-0.19%) ▼|MU909.62+4.72 (+0.52%) ▲|NEE78.83+0.66 (+0.84%) ▲|NFLX69.29-0.56 (-0.80%) ▼|NKE37.95+0.74 (+1.98%) ▲|NOW149.61+4.25 (+2.92%) ▲|NVDA217.09+0.00 (+0.00%) ▲|ORCL131.78+2.19 (+1.69%) ▲|PEP134.26+0.69 (+0.52%) ▲|PFE30.24+0.80 (+2.70%) ▲|PG158.22+0.53 (+0.33%) ▲|PLTR195.76+1.61 (+0.83%) ▲|PM200.05-1.00 (-0.50%) ▼|QCOM176.25+2.72 (+1.57%) ▲|RTX191.57-0.55 (-0.28%) ▼|SBUX99.44+1.57 (+1.60%) ▲|SCHW90.69+1.11 (+1.24%) ▲|SO90.80+1.53 (+1.71%) ▲|SPG205.95+3.46 (+1.71%) ▲|T23.55+0.35 (+1.49%) ▲|TMO690.26+10.88 (+1.60%) ▲|TMUS157.96+1.87 (+1.20%) ▲|TSLA374.66+6.60 (+1.79%) ▲|TXN279.33+3.18 (+1.15%) ▲|UBER69.00-0.96 (-1.37%) ▼|UNH420.66+13.78 (+3.39%) ▲|UNP288.10+1.09 (+0.38%) ▲|UPS99.00+1.54 (+1.58%) ▲|USB58.91+1.06 (+1.83%) ▲|V407.29+4.37 (+1.08%) ▲|VZ44.56+0.41 (+0.92%) ▲|WFC81.64-0.17 (-0.20%) ▼|WMT118.35-0.35 (-0.29%) ▼|XOM177.16-1.12 (-0.63%) ▼|AAPL339.84-3.11 (-0.91%) ▼|ABBV290.72+8.04 (+2.85%) ▲|ABT102.61-1.46 (-1.40%) ▼|ACN238.96+2.03 (+0.86%) ▲|ADBE255.26+8.17 (+3.30%) ▲|AMAT406.46-6.65 (-1.61%) ▼|AMD542.18+4.13 (+0.77%) ▲|AMGN434.83+9.89 (+2.33%) ▲|AMT184.65+1.62 (+0.88%) ▲|AMZN263.10+0.65 (+0.25%) ▲|AVGO335.28+0.69 (+0.21%) ▲|AXP319.86+3.45 (+1.09%) ▲|BA191.31-0.12 (-0.06%) ▼|BAC50.80+0.41 (+0.81%) ▲|BKNG164.47+1.87 (+1.15%) ▲|BLK1,129.24+4.64 (+0.41%) ▲|BMY61.60+2.77 (+4.71%) ▲|BNY144.36+1.92 (+1.35%) ▲|BRK-B537.93+5.70 (+1.07%) ▲|C122.39+0.70 (+0.58%) ▲|CAT726.45+0.66 (+0.09%) ▲|CL94.02+1.16 (+1.24%) ▲|CMCSA22.21+0.31 (+1.39%) ▲|COF201.93+2.10 (+1.05%) ▲|COP145.84+0.60 (+0.41%) ▲|COST995.38-0.15 (-0.02%) ▼|CRM242.07-0.39 (-0.16%) ▼|CSCO106.63+0.13 (+0.12%) ▲|CVS94.11+1.43 (+1.54%) ▲|CVX224.76+0.39 (+0.17%) ▲|DE636.27+9.27 (+1.48%) ▲|DHR225.45+1.02 (+0.45%) ▲|DIS111.60+2.01 (+1.83%) ▲|DUK121.25+1.98 (+1.66%) ▲|EMR159.79-0.76 (-0.47%) ▼|FDX300.57+6.79 (+2.31%) ▲|GD344.41+2.98 (+0.87%) ▲|GE299.48-11.80 (-3.79%) ▼|GEV896.82-11.62 (-1.28%) ▼|GILD156.32+3.25 (+2.12%) ▲|GM75.90-6.86 (-8.28%) ▼|GOOG336.78-3.38 (-0.99%) ▼|GOOGL340.69-3.49 (-1.01%) ▼|GS885.74+9.96 (+1.14%) ▲|HD315.78+5.90 (+1.90%) ▲|HON212.18+2.20 (+1.05%) ▲|IBM240.33+3.94 (+1.67%) ▲|INTC92.54+0.51 (+0.55%) ▲|INTU336.52+10.90 (+3.35%) ▲|ISRG438.78+5.60 (+1.29%) ▲|JNJ259.72+5.93 (+2.34%) ▲|JPM335.76+2.23 (+0.67%) ▲|KO92.75-0.68 (-0.72%) ▼|LIN499.70-3.75 (-0.74%) ▼|LLY1,292.02+51.68 (+4.17%) ▲|LMT549.29+1.06 (+0.19%) ▲|LOW199.33+3.41 (+1.74%) ▲|LRCX265.14-7.06 (-2.59%) ▼|MA622.00+5.60 (+0.91%) ▲|MCD245.62+2.95 (+1.21%) ▲|MDLZ63.87+0.53 (+0.83%) ▲|MDT94.57+1.80 (+1.94%) ▲|META690.14-15.30 (-2.17%) ▼|MMM171.17+9.16 (+5.65%) ▲|MO74.43+0.34 (+0.46%) ▲|MRK148.25+4.62 (+3.22%) ▲|MS180.42+1.95 (+1.09%) ▲|MSFT532.48-1.04 (-0.19%) ▼|MU909.62+4.72 (+0.52%) ▲|NEE78.83+0.66 (+0.84%) ▲|NFLX69.29-0.56 (-0.80%) ▼|NKE37.95+0.74 (+1.98%) ▲|NOW149.61+4.25 (+2.92%) ▲|NVDA217.09+0.00 (+0.00%) ▲|ORCL131.78+2.19 (+1.69%) ▲|PEP134.26+0.69 (+0.52%) ▲|PFE30.24+0.80 (+2.70%) ▲|PG158.22+0.53 (+0.33%) ▲|PLTR195.76+1.61 (+0.83%) ▲|PM200.05-1.00 (-0.50%) ▼|QCOM176.25+2.72 (+1.57%) ▲|RTX191.57-0.55 (-0.28%) ▼|SBUX99.44+1.57 (+1.60%) ▲|SCHW90.69+1.11 (+1.24%) ▲|SO90.80+1.53 (+1.71%) ▲|SPG205.95+3.46 (+1.71%) ▲|T23.55+0.35 (+1.49%) ▲|TMO690.26+10.88 (+1.60%) ▲|TMUS157.96+1.87 (+1.20%) ▲|TSLA374.66+6.60 (+1.79%) ▲|TXN279.33+3.18 (+1.15%) ▲|UBER69.00-0.96 (-1.37%) ▼|UNH420.66+13.78 (+3.39%) ▲|UNP288.10+1.09 (+0.38%) ▲|UPS99.00+1.54 (+1.58%) ▲|USB58.91+1.06 (+1.83%) ▲|V407.29+4.37 (+1.08%) ▲|VZ44.56+0.41 (+0.92%) ▲|WFC81.64-0.17 (-0.20%) ▼|WMT118.35-0.35 (-0.29%) ▼|XOM177.16-1.12 (-0.63%) ▼|
20.2 C
New York
Tuesday, October 20, 2026

Tag: diseases

newsFORsourcecompanycontentinformation1releasesmarket

IDEAYA Biosciences and Servier Announce Data From Three Clinical Trials at ESMO 2026 Supporting the Potential of Darovasertib to Become a Foundational New Therapy...

OptimUM-01 and OptimUM-02 data supports the broad potential of darovasertib plus crizotinib to drive meaningful clinical benefits for patients with metastatic uveal melanoma, irrespective...

Sobi to present new Aspaveli®/Empaveli® data at ASN Kidney Week 2026

STOCKHOLM, Oct. 19, 2026 /PRNewswire/ -- Sobi® today announced that seven abstracts on Aspaveli/Empaveli (pegcetacoplan) have been accepted for presentation at the American Society...

Lilly’s Omvoh (mirikizumab-mrkz) meets primary endpoint of clinical remission and is the first IL-23p19 inhibitor to report one-year Phase 3 results in pediatric ulcerative...

Building on Omvoh's approved use and durable efficacy in adults, Lilly plans to submit these data to global regulators to support a potential label...

AbbVie Presents Data for ABBV-466, a Novel Dual-Targeting Therapy Demonstrating Higher Endoscopic Remission Rates Than Either Anti-IL-23 or Anti-α4β7 Monotherapy in Moderate to Severe...

In a Phase 2a study, ABBV-466 achieved higher endoscopic remission rates in patients with Crohn's disease than either anti-IL-23 p19 or anti-α4β7 monotherapy at...

Ultima Genomics Selected for Landmark Large-Scale Immune Profiling Study with IMU Biosciences, UK Biobank and Waters Corporation

IMU Biosciences and UK Biobank will generate a single-cell immune profiling AI foundational dataset from 80,000 blood samples collected from UK Biobank participants using Ultima...

HISTOINDEX AND A*STAR PARTNER TO ADVANCE EARLY-STAGE DEVELOPMENT OF PIPELINE THERAPIES FOR FIBROTIC DISEASES

SINGAPORE, Oct. 19, 2026 /PRNewswire/ -- HistoIndex, a pioneer in AI-driven digital pathology for fibrotic diseases, and the Agency for Science, Technology and Research (A*STAR),...

HISTOINDEX AND A*STAR PARTNER TO ADVANCE EARLY-STAGE DEVELOPMENT OF PIPELINE THERAPIES FOR FIBROTIC DISEASES

SINGAPORE, Oct. 18, 2026 /PRNewswire/ -- HistoIndex, a pioneer in AI-driven digital pathology for fibrotic diseases, and the Agency for Science, Technology and Research (A*STAR),...

ESMO 2026 Preview | Mabwell to Present Clinical Results for Nectin-4-Targeting ADC 9MW2821 in ADC-Pretreated Triple-Negative Breast Cancer

SHANGHAI, Oct. 18, 2026 /PRNewswire/ -- Mabwell (688062.SH, 02493.HK), an innovation-driven biopharmaceutical company with a fully integrated industry chain, will present Phase II clinical...

Lilly to showcase advances across its oncology pipeline at the 2026 European Society for Medical Oncology (ESMO) Congress

First Phase 1 data for sofetabart mipitecan, Lilly's investigational FRα-targeting ADC, in platinum-sensitive ovarian cancer to be featured in a rapid oral presentationUpdated first-line...

Changes to the Board of Directors of H. Lundbeck A/S

Dorothea Wenzel, Chair of the Board, has informed the Board that she will step down in connection with the Annual General Meeting in 2027. Following...

Changes to the Board of Directors of H. Lundbeck A/S

Dorothea Wenzel, Chair of the Board, has informed the Board that she will step down in connection with the Annual General Meeting in 2027. Following...

UEG launches new Patient Representatives Advisory Board to strengthen patient voice in digestive health

United European Gastroenterology (UEG) has today launched its new Patient Representatives Advisory Board (PRAB), creating a dedicated platform to embed patient perspectives within its...

Abu Dhabi Health Delegation Concludes Inaugural Visit to China, Opening New Pathways to Advance AI, Precision Medicine and Next-Gen Therapies

ABU DHABI, UAE, Oct. 18, 2026 /PRNewswire/ -- The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the...

Abu Dhabi Health Delegation Concludes Inaugural Visit to China, Opening New Pathways to Advance AI, Precision Medicine and Next-Gen Therapies

ABU DHABI, UAE, Oct. 17, 2026 /PRNewswire/ -- The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsDiseases

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers